Achilles Therapeutics | 6-K:外国发行人报告
Achilles Therapeutics | 6-K:外国发行人报告(业绩相关)
Achilles Therapeutics | S-8:员工福利计划证券登记
Achilles Therapeutics | 20-F:年度报告/过渡报告/注册声明
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Invus Public Equities, L.P.(1.9%),Invus Public Equities Advisors, LLC(1.9%)等
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(8.1%),Baker Bros. Advisors (GP) LLC(8.1%)等
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Achilles Therapeutics | 144:拟议出售证券
Achilles Therapeutics | 6-K:外国发行人报告(业绩相关)
Achilles Therapeutics | 144:拟议出售证券
Achilles Therapeutics | 6-K:外国发行人报告
Achilles Therapeutics | 144:拟议出售证券
Achilles Therapeutics | 6-K:外国发行人报告(业绩相关)
Achilles Therapeutics | 6-K:外国发行人报告
Achilles Therapeutics | 6-K:外国发行人报告(业绩相关)
Achilles Therapeutics | 6-K:外国发行人报告
Achilles Therapeutics | S-8:员工福利计划证券登记
Achilles Therapeutics:2022财年年报
20-F | Achilles Therapeutics plc (0001830749) (Filer)
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Redmile Group, LLC(3.9%),Jeremy C. Green(3.9%)
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(9.9%),Baker Bros. Advisors (GP) LLC(9.9%)等
暂无数据